drugset / Trial / NCT06699329
A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
NaSingle-groupOpen-labelBasic science
Summary
The goal of this study is to learn what happens in a person's body over time when they take enlicitide decanoate and semaglutide alone or at the same time. Enlicitide decanoate is a new medicine that lowers the amount of cholesterol in a person's blood. Semaglutide is a drug used to treat type 2 diabetes. Researchers want to learn what happens to the amount of semaglutide and enlicitide decanoate in a person's blood when each drug is taken alone and when they are taken together.
Timeline
- Start
- 2024-01-22
- Primary completion
- 2024-05-24
- Completion
- 2024-05-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enlicitide Decanoate | Unknown | — | Oral |
| Subject | Semaglutide | Peptide | — | Oral |
Indications
No indication recorded.